AD109 (Oxnimbi) — PDUFA
Feb 28
Apnimed's NDA for AD109 is under review by the FDA and was assigned a PDUFA goal date of February 28, 2027.Source filing
APMD biotech catalysts & pipeline
APNIMED INC · Data as of 2026-10-25
catalyst calendar
/
catalyst calendar
APNIMED INC · Data as of 2026-10-25
Feb 28
Apnimed's NDA for AD109 is under review by the FDA and was assigned a PDUFA goal date of February 28, 2027.Source filing